Organ Meats for Heart and CoQ10

Beef heart is the densest concentrated dietary source of CoQ10 (coenzyme Q10, ubiquinone) in the human food supply, at approximately 113 mg/kg fresh weight — a single 3-oz serving provides roughly 10 mg of CoQ10, comparable to a low-dose supplement capsule, embedded in its native cardiolipin-bound phospholipid context. Heart muscle is also exceptionally rich in taurine (the conditionally essential amino acid concentrated in cardiac tissue), L-carnitine (required for mitochondrial fatty-acid oxidation), selenium, B-complex vitamins, and the entire mitochondrial protein machinery that the human heart needs to maintain itself. Beef heart is leaner than steak (the cut is muscle, not organ in the traditional sense), tender when properly cooked, and grills like skirt or flank with a mild, slightly beefy flavor that is much more accessible than liver. The case is straightforward: if you want to support your own heart muscle's mitochondrial function, eat the same nutrients in the same context that another animal's heart used to do the same job. This deep-dive walks through the CoQ10 case, the statin-induced CoQ10 depletion picture, the taurine and L-carnitine contribution, and the practical question of how often to eat beef heart for cardiovascular support.

Table of Contents

  1. Beef Heart Is Muscle, Not Organ Tissue
  2. CoQ10 Density in Beef Heart vs Other Foods
  3. What CoQ10 Does — The Electron Transport Chain
  4. Age-Related Decline in Tissue CoQ10
  5. Statin-Induced CoQ10 Depletion
  6. The Q-SYMBIO Trial — CoQ10 in Heart Failure
  7. Taurine — The Conditionally Essential Cardiac Amino Acid
  8. L-Carnitine — Mitochondrial Fatty Acid Transport
  9. Cardiolipin and the Native Phospholipid Context
  10. Cooking Beef Heart and Recommended Frequency
  11. Cautions
  12. Key Research Papers
  13. Connections

Beef Heart Is Muscle, Not Organ Tissue

One of the most useful facts to communicate to a beef-heart-curious eater is that the heart is anatomically muscle — specifically a specialized cardiac striated muscle — and it cooks, tastes, and chews like very lean steak. It is not the soft, custard-like texture of liver, nor the strong flavor of kidney. Beef heart has a tighter, slightly chewier grain than ribeye but a remarkably similar flavor profile: a deep, mineral-rich beefiness without the strong “organ” notes that turn off many liver-averse eaters.

This matters because the cultural barrier to organ-meat consumption is largely a flavor and texture barrier. Beef heart slides past most of that resistance. A trimmed beef heart, sliced thin against the grain, marinated for a couple of hours in olive oil, garlic, and herbs, and seared briefly on a hot grill or cast-iron pan, eats like a particularly flavorful skirt steak. Argentine asado tradition treats grilled beef heart (corazon) as a delicacy on par with the best cuts of muscle meat. Peruvian anticuchos — skewered marinated beef heart grilled over charcoal — have been a national street food for centuries.

What makes beef heart special is not its texture (which is mainstream-acceptable) but its nutrient density (which is far above mainstream cuts of beef). Per ounce, beef heart provides several-fold more CoQ10, taurine, riboflavin, B12, and selenium than ribeye, sirloin, or chuck. The combination of accessible flavor and exceptional nutrient density makes it arguably the best “gateway organ meat” for adults trying to expand beyond muscle cuts.

Back to Table of Contents

CoQ10 Density in Beef Heart vs Other Foods

CoQ10 concentration varies enormously across foods. The general principle is that tissues with high mitochondrial density (which is to say, tissues that work hard metabolically) carry the most CoQ10. Mature human hearts contain approximately 110-130 mg/kg; the same tissue in cattle is similar. Beef heart at 113 mg/kg is therefore the densest food-source of CoQ10 available in the Western food supply. For comparison:

The implication is that even with a relatively diverse Western diet, the total dietary CoQ10 intake from typical food choices is approximately 3-6 mg/day. A single 3-oz serving of beef heart approximately triples that. For someone with elevated CoQ10 needs — older adults, anyone taking a statin, anyone with heart failure or migraine — replacing one or two weekly meals of muscle meat with beef heart provides a meaningful CoQ10 boost without supplement cost.

For the full discussion of CoQ10 biology and supplementation see our CoQ10 page.

Back to Table of Contents

What CoQ10 Does — The Electron Transport Chain

CoQ10 (ubiquinone in its oxidized form, ubiquinol in its reduced form) is a small, lipid-soluble quinone that sits in the inner mitochondrial membrane and serves as the mobile electron carrier between Complex I (or Complex II) and Complex III of the electron transport chain. Without functional CoQ10, the proton-pumping electron transport that generates the proton-motive force driving ATP synthesis cannot proceed. Cells that fail mitochondrial energy production die rapidly, and tissues that are particularly metabolically demanding — heart, kidney, liver, brain, and skeletal muscle — suffer first.

CoQ10 has a secondary role as a lipid-soluble antioxidant, scavenging reactive oxygen species in mitochondrial and cellular membranes, regenerating Vitamin E, and protecting membrane phospholipids from peroxidation. Both functions are essential, and both decline together when CoQ10 is depleted.

CoQ10 synthesis from the cholesterol/mevalonate pathway is the body's primary source for most adults, but biosynthesis declines with age (typical 50-year-old hearts contain about half the CoQ10 of typical 20-year-old hearts in autopsy series), with chronic illness, and with HMG-CoA reductase inhibitor (statin) therapy. Dietary CoQ10 intake supplements endogenous synthesis modestly — the absolute absorbed dose is small, but bioavailability of food-form CoQ10 in beef heart is somewhat better than dry-powder supplement forms because the lipid context aids absorption.

Back to Table of Contents

The age-related decline in tissue CoQ10 concentration is one of the most consistent biochemical findings in human aging. Kalen et al. (Acta Anatomica 1989) measured CoQ10 in human autopsy tissues across the lifespan and documented a roughly 50% decline in heart, kidney, and skeletal muscle CoQ10 between ages 20 and 70. The decline begins around age 30 and accelerates after age 50. Brain CoQ10 also declines but less dramatically.

The mechanism is multifactorial: reduced biosynthesis from the mevalonate pathway, increased oxidative consumption of CoQ10 as cellular oxidative stress rises, accumulated mitochondrial DNA damage reducing functional mitochondrial mass, and reduced dietary CoQ10 intake in the elderly (who often eat fewer organ meats, fish, and meat in general). The functional consequence is reduced mitochondrial ATP output per gram of tissue, which contributes to the well-documented decline in cardiac contractile reserve, exercise capacity, and skeletal muscle quality with age.

Supplementation studies have shown that oral CoQ10 modestly raises plasma and tissue concentrations, and clinical trials of CoQ10 in age-related conditions (heart failure, neurodegenerative disease, migraine) have generated mixed but cumulatively encouraging results. Beef heart consumption provides a parallel dietary route that may be equally effective, with the added benefit of providing taurine, L-carnitine, and B vitamins in the same meal.

Back to Table of Contents

Statin-Induced CoQ10 Depletion

Statins (atorvastatin, simvastatin, rosuvastatin, pravastatin, and the others) work by inhibiting HMG-CoA reductase, the rate-limiting enzyme in the mevalonate pathway. The mevalonate pathway produces cholesterol — the intended target — but it also produces CoQ10, dolichols, isoprenoids, and several other essential metabolites. Inhibition of HMG-CoA reductase reduces all of these downstream products in proportion to dose and duration of therapy.

Multiple studies have documented that statin therapy reduces serum CoQ10 by approximately 16-54% depending on dose and duration. Tissue CoQ10 concentrations also fall, though the extent of muscle and heart tissue depletion has been harder to measure directly in humans. The clinical correlate — statin-induced myopathy, ranging from mild muscle aches to rare severe rhabdomyolysis — is plausibly driven in part by CoQ10 depletion in skeletal muscle mitochondria.

The clinical practice question of whether to supplement CoQ10 alongside statin therapy is debated. Several systematic reviews have found modest benefit for muscle symptoms (Banach 2018 meta-analysis, for example, found reduction in statin-associated muscle symptoms). The European Cardiology Society and several specialty societies recommend considering CoQ10 supplementation (typically 100-200 mg/day) for patients experiencing statin-related muscle symptoms.

For dietary support, replacing one or two weekly meals of muscle meat with beef heart provides supplemental dietary CoQ10 alongside the rest of the cardiac-supportive nutrient profile — a particularly useful adjunct for the statin-using patient who would also benefit from increased taurine and L-carnitine intake.

Back to Table of Contents

The Q-SYMBIO Trial — CoQ10 in Heart Failure

The Q-SYMBIO trial (Mortensen et al., JACC Heart Failure 2014) is the largest and most rigorous trial of CoQ10 supplementation in heart failure. Investigators randomized 420 patients with moderate to severe heart failure (NYHA Class III or IV, ejection fraction below 35%) to CoQ10 100 mg three times daily versus placebo for two years, in addition to standard guideline-directed medical therapy.

Results favored the CoQ10 arm substantially:

Q-SYMBIO was a smaller trial than the typical heart-failure trial (the major statin and beta-blocker trials enrolled 4,000-20,000 patients), and its results have not been reproduced at the same magnitude in larger follow-on studies. But Q-SYMBIO remains the strongest single piece of evidence that CoQ10 has a measurable clinical effect in heart failure, and it forms part of the rationale behind dietary CoQ10 strategies for cardiac-compromised patients.

For the broader treatment of heart failure see our Congestive Heart Failure page.

Back to Table of Contents

Taurine — The Conditionally Essential Cardiac Amino Acid

Taurine is a sulfur-containing amino acid that the human body can synthesize in small amounts from cysteine but typically needs dietary supplementation to maintain optimal levels. It is the most abundant free amino acid in the heart, brain, and skeletal muscle — in heart muscle it accounts for approximately 50% of the total free amino acid pool. Taurine is conditionally essential, meaning that under conditions of stress, chronic illness, or increased metabolic demand, dietary intake becomes necessary.

The cardiac functions of taurine include calcium handling (taurine modulates the L-type calcium channel and sarcoplasmic reticulum calcium reuptake), osmotic regulation (intracellular taurine balances cytoplasmic osmolarity), bile acid conjugation (relevant to fat absorption), and direct antioxidant effects. Cats — which cannot synthesize taurine endogenously — develop dilated cardiomyopathy on a taurine-deficient diet, and the discovery in the 1980s that taurine supplementation reversed this DCM was a major veterinary cardiology landmark.

In humans, taurine supplementation has shown modest benefit in clinical trials of congestive heart failure (Beyranvand 2011, Azuma 1985) with improvements in ejection fraction and exercise tolerance at doses of 3-6 g/day. Beef heart is the densest dietary source of taurine in common Western foods (approximately 650 mg per 3-oz serving), substantially higher than muscle meat (200-400 mg) or fish (150-300 mg). For taurine biology see our Taurine page.

Back to Table of Contents

L-Carnitine — Mitochondrial Fatty Acid Transport

L-carnitine is required to shuttle long-chain fatty acids across the mitochondrial inner membrane via the carnitine palmitoyltransferase (CPT-I and CPT-II) system. Without adequate L-carnitine, long-chain fatty acids accumulate in the cytoplasm and cannot be oxidized for ATP production. The heart, which derives 60-90% of its ATP from fatty acid oxidation, is particularly vulnerable to L-carnitine deficiency.

The body synthesizes L-carnitine from lysine and methionine in the liver and kidney, but dietary intake supplements endogenous synthesis substantially. Red meat is the primary food source (the name “carnitine” derives from carnis, the Latin for flesh). Beef heart is particularly dense (approximately 90 mg per 3-oz serving). Strict vegetarians have measurably lower plasma carnitine concentrations than omnivores, though this is rarely clinically symptomatic at typical activity levels.

L-carnitine supplementation has been studied in heart failure, intermittent claudication (peripheral arterial disease), and myocardial infarction recovery, with several meta-analyses suggesting modest benefit in mortality and functional outcomes (the DiNicolantonio 2013 meta-analysis pooled 13 trials and 3,629 patients with acute MI and found a 27% reduction in all-cause mortality with L-carnitine supplementation, though the result has been debated). For beef heart consumers, the L-carnitine content adds to the broader picture of mitochondrial support.

Back to Table of Contents

Cardiolipin and the Native Phospholipid Context

One of the underappreciated advantages of eating heart tissue versus taking dry CoQ10 supplements is that the CoQ10 in heart muscle is embedded in its native cardiolipin-containing phospholipid context. Cardiolipin is a tetra-acyl phospholipid unique to the inner mitochondrial membrane, where it interacts intimately with Complex III, Complex IV, and the F1F0 ATP synthase. Cardiolipin scaffolds the supercomplexes of the electron transport chain and is essential for efficient electron flow.

Dietary cardiolipin from heart consumption is largely hydrolyzed during digestion to free fatty acids and glycerophosphoglycerol, but the lipid context during absorption may improve the bioavailability of co-absorbed CoQ10 versus dry powder forms. The combination of food-form CoQ10 plus the broader lipid context of cardiac muscle may produce somewhat better tissue uptake than equivalent dose of dry supplement — though direct comparative bioavailability studies are limited.

For the purposes of clinical recommendation, beef heart consumption can be considered a parallel and partly complementary strategy to CoQ10 supplementation rather than a strict substitute. Some patients with high CoQ10 needs use both.

Back to Table of Contents

Cooking Beef Heart and Recommended Frequency

Beef heart is sold whole (typically 3-5 pounds) or trimmed and butterflied at well-stocked butcher shops. Trimming involves removing the heavy fascia, larger blood vessels, and any remaining valve tissue from the interior. The remaining muscle is lean, dense, and divides naturally into chambers that can be cut into steaks (approximately 1/2 inch thick) or strips for stir-fry or skewers.

Cooking principles:

Recommended frequency: one 3-oz serving of beef heart per week provides approximately 10 mg of dietary CoQ10, 650 mg of taurine, 90 mg of L-carnitine, plus excellent B-complex and selenium content — without crossing into purine or saturated-fat concerns. For patients with documented CoQ10-relevant conditions (heart failure, statin-induced myopathy, migraine, age-related fatigue) two servings per week is reasonable. Substituting beef heart for one weekly meal of muscle steak essentially trades nothing nutritionally meaningful and gains substantial mitochondrial cofactor density.

Back to Table of Contents

Cautions

Back to Table of Contents

Key Research Papers

  1. Mortensen SA et al. (2014). The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC: Heart Failure. — PubMed: Q-SYMBIO 2014
  2. Kalen A, Appelkvist EL, Dallner G (1989). Age-related changes in the lipid compositions of rat and human tissues. Lipids. — PubMed: Kalen 1989 tissue CoQ10
  3. Banach M et al. (2018). Statin therapy and plasma coenzyme Q10 concentrations — a systematic review and meta-analysis of placebo-controlled trials. Pharmacological Research. — PubMed: Banach 2018
  4. Banach M et al. (2015). Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. Mayo Clinic Proceedings. — PubMed: Banach myopathy meta-analysis
  5. DiNicolantonio JJ et al. (2013). L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Mayo Clinic Proceedings. — PubMed: DiNicolantonio L-carnitine
  6. Mathew BC, Biju RS (2008). Neuroprotective effects of garlic. A review. Libyan Journal of Medicine. (taurine antioxidant context) — PubMed: Taurine cardiac protection
  7. Beyranvand MR et al. (2011). Effect of taurine supplementation on exercise capacity of patients with heart failure. Journal of Cardiology. — PubMed: Beyranvand taurine HF
  8. Azuma J et al. (1985). Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. Clinical Cardiology. — PubMed: Azuma 1985
  9. Pravst I et al. (2010). Coenzyme Q10 contents in foods and fortification strategies. Critical Reviews in Food Science and Nutrition. — PubMed: CoQ10 food content review
  10. Mantle D, Hargreaves IP (2019). Coenzyme Q10 and degenerative disorders affecting longevity: an overview. Antioxidants. — PubMed: Mantle & Hargreaves 2019
  11. Schaffer SW, Kim HW (2018). Effects and mechanisms of taurine as a therapeutic agent. Biomolecules & Therapeutics. — PubMed: Schaffer taurine review
  12. Pepe S et al. (2007). Coenzyme Q10 in cardiovascular disease. Mitochondrion. — PubMed: Pepe CoQ10 CV review

PubMed Topic Searches

Back to Table of Contents

Connections

Back to Table of Contents